How long to use Mounjaro: a step-by-step guide to duration, stopping and staying on track

Step 1, the titration period (weeks 1 to roughly 20): adjusting, not yet at full effect

Treatment begins at 2.5mg, a dose whose job is to let your digestive system adapt rather than to produce dramatic weight change. Most people notice mild appetite reduction fairly quickly, but the settling-in phase can take several weeks before side effects calm down. From there, the dose climbs in 4-week steps (5mg, 7.5mg, 10mg, 12.5mg, up to 15mg) guided by tolerability. That means the first four or five months of treatment are often a titration journey as much as a weight-loss one.

Many patients don't reach their highest tolerated dose until around month four or five. If you're wondering why progress feels slower in the early weeks, it's usually because the medicine is still finding its working level. The full picture of how long weight loss takes on Mounjaro becomes clearer once titration is complete. Your prescriber at each clinical review will look at both tolerability and response before recommending the next step.

Step 2 (the active treatment window (months 3 to 12 and beyond): when results build

In the SURMOUNT-1 trial) 2,539 adults with obesity, followed for 72 weeks, participants lost an average of around 20–21% of their body weight at the 15mg dose by the end of the study, published in the New England Journal of Medicine. The bulk of that weight loss accumulated progressively from months three to twelve, with the curve flattening thereafter as the body reached a new equilibrium. That trajectory matters for understanding how long to use Mounjaro: stopping at month three, before titration is even complete, cuts the benefit dramatically short.

There is no upper time limit written into the UK licence for tirzepatide. Prescribers continue treatment for as long as it is effective and well tolerated, reviewing at each repeat. NICE guidance (TA1026) does set a practical checkpoint: if someone hasn't lost at least 5% of their starting weight after six months on the highest dose they can tolerate, the prescriber should reassess whether continuing is worthwhile. That's a clinical check, not a cliff edge, it protects people from staying on a medicine that isn't helping them.

You can read a fuller account of the recommended duration of Mounjaro and how the NICE review threshold works in practice.

Step 3, reviewing, stopping or staying on: what the evidence says about weight regain

Weight regain after stopping GLP-1 medicines is well documented. The biology is straightforward: tirzepatide works while you take it, reducing appetite signals through its dual action on GIP and GLP-1 receptors; when the medicine clears, those signals gradually return. Many people find that the habits built during treatment (smaller portions, less impulsive snacking, a better relationship with hunger) persist to some degree, but they rarely fully compensate for the pharmacological effect being removed.

This is why stopping Mounjaro is a planned clinical conversation, not something to do because a pen ran out on a Tuesday. A prescriber can discuss tapering, lifestyle reinforcement, or whether there is a clinical case for continuing. The timeline of Mounjaro's effects in reverse (how quickly appetite returns and what to expect) is something our prescribers talk through regularly with patients approaching that stage.

For context on how private treatment is priced over a longer course, the Eli Lilly UK price increase in September 2025 changed the cost picture for many patients, and it's worth understanding that before committing to an extended programme.

Step 4, what a sensible long-term plan looks like

A realistic timeline for most people who respond well: titration through month five, progressive weight loss through month twelve, then a review of whether to continue, adjust the dose downward for maintenance, or begin a structured exit. Some people (particularly those managing type 2 diabetes alongside obesity) have strong clinical reasons to stay on tirzepatide indefinitely. Others reach a stable weight and work with their prescriber on a planned withdrawal.

There's no one correct answer to how long you use Mounjaro. What's clear from the evidence and from our clinical team's experience is that duration is always a clinical decision, made by reviewing progress, side-effect profile and the patient's overall health picture, not by a fixed rule or a calendar. If you're thinking about starting or are already partway through treatment and wondering about next steps, a conversation with a prescriber is the place to start. You can speak to our prescribers through a free consultation, with no waiting list.